Pharmaceuticals in Mexico - Research and Markets

Pharmaceuticals in Mexico industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
The Mexican pharmaceuticals market registered revenues of $17.7 billion in 2023, representing a compound annual growth rate (CAGR) of 7% between 2018 and 2023.
Mexico captured a share of 2.9% in the American pharmaceuticals market, in 2023.

Scope

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Mexico
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Mexico
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Mexico pharmaceuticals market with five year forecasts

Reasons to Buy

What was the size of the Mexico pharmaceuticals market by value in 2023?
What will be the size of the Mexico pharmaceuticals market in 2028?
What factors are affecting the strength of competition in the Mexico pharmaceuticals market?
How has the market performed over the last five years?
What are the main segments that make up Mexico's pharmaceuticals market?

1 Executive Summary

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape

2 Market Overview

2.1. Market definition
2.2. Market analysis

3 Market Data

3.1. Market value

4 Market Segmentation

4.1. Geography segmentation

5 Market Outlook

5.1. Market value forecast

6 Five Forces Analysis

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape

7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the recent developments in the market?

8 Company Profiles

8.1. Bayer de Mexico SA de CV
8.2. Boehringer Ingelheim Mexico
8.3. Sanofi-Aventis de Mexico SA de CV
8.4. Genomma Lab Internacional SAB de CV

9 Macroeconomic Indicators

9.1. Country data

10 Appendix

10.1. Methodology
10.2. Industry associations
10.3. Related research
10.4. About the Publisher

List of Tables

Table 1: Mexico pharmaceuticals market value: $ billion, 2018-23
Table 2: Mexico pharmaceuticals market geography segmentation: $ billion, 2023
Table 3: Mexico pharmaceuticals market value forecast: $ billion, 2023-28
Table 4: Bayer de Mexico SA de CV: Key Facts
Table 5: Bayer de Mexico SA de CV: Key Employees
Table 6: Boehringer Ingelheim Mexico: Key Facts
Table 7: Boehringer Ingelheim Mexico: Key Employees
Table 8: Sanofi-Aventis de Mexico SA de CV: Key Facts
Table 9: Genomma Lab Internacional SAB de CV: Key Facts
Table 10: Genomma Lab Internacional SAB de CV: Annual Financial Ratios
Table 11: Genomma Lab Internacional SAB de CV: Key Employees
Table 12: Mexico Size of Population (million), 2019-23
Table 13: Mexico Real GDP (constant 2010 prices, $ billion), 2019-23
Table 14: Mexico GDP (current prices, $ billion), 2019-23
Table 15: Mexico Inflation, 2019-23
Table 16: Mexico Consumer Price Index (absolute), 2019-23
Table 17: Mexico Exchange Rate, 2018-23

List of Figures

Figure 1: Mexico pharmaceuticals market value: $ billion, 2018-23
Figure 2: Mexico pharmaceuticals market geography segmentation: % share, by value, 2023
Figure 3: Mexico pharmaceuticals market value forecast: $ billion, 2023-28
Figure 4: Forces driving competition in the pharmaceuticals market in Mexico, 2023
Figure 5: Drivers of buyer power in the pharmaceuticals market in Mexico, 2023
Figure 6: Drivers of supplier power in the pharmaceuticals market in Mexico, 2023
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2023
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2023
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Bayer de Mexico SA de CV
Boehringer Ingelheim Mexico
Sanofi-Aventis de Mexico SA de CV
Genomma Lab Internacional SAB de CV

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€352EUR$350USD£296GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€528EUR$525USD£444GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€704EUR$700USD£592GBP

Key Highlights

Scope

Reasons to Buy

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Pharmaceutical Industry Outlook, 2024

Fecal Transplant Therapy Market Report 2024

Pharmaceuticals North America (NAFTA) Industry Guide 2019-2028

Pharmaceuticals Top 5 Emerging Markets Industry Guide 2019-2028

Pharmaceutical Drugs Global Market Report 2024